Short Interest in Bath & Body Works, Inc. (NYSE:BBWI) Decreases By 22.8%

Bath & Body Works, Inc. (NYSE:BBWIGet Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 5,720,000 shares, a decline of 22.8% from the March 15th total of 7,410,000 shares. Currently, 2.9% of the company’s shares are short sold. Based on an average daily trading volume, of 5,240,000 shares, the days-to-cover ratio is currently 1.1 days.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Bath & Body Works from $47.00 to $41.00 and set an “overweight” rating on the stock in a research note on Monday, April 14th. Wells Fargo & Company raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Barclays dropped their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a research note on Monday, March 3rd. Citigroup cut their price target on shares of Bath & Body Works from $48.00 to $36.00 and set a “buy” rating on the stock in a report on Monday, April 7th. Finally, Cowen reiterated a “buy” rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $43.13.

View Our Latest Stock Report on Bath & Body Works

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in BBWI. Fifth Third Wealth Advisors LLC increased its position in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after purchasing an additional 324 shares in the last quarter. SRS Capital Advisors Inc. raised its holdings in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the last quarter. Northwest Bank & Trust Co increased its position in Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company’s stock worth $533,000 after purchasing an additional 419 shares during the last quarter. Finally, Lindbrook Capital LLC raised its stake in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

Bath & Body Works stock traded down $0.64 during trading on Monday, reaching $27.78. The company had a trading volume of 3,277,563 shares, compared to its average volume of 5,238,248. The firm’s 50-day simple moving average is $32.15 and its 200 day simple moving average is $33.90. The firm has a market capitalization of $5.95 billion, a PE ratio of 6.78, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. Bath & Body Works has a 1-year low of $24.96 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.

Bath & Body Works announced that its board has approved a share buyback plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its shares are undervalued.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Further Reading

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.